These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24757084)

  • 1. The efficacy and safety of ivabradine hydrochloride versus atenolol in Chinese patients with chronic stable angina pectoris.
    Li Y; Jing L; Li Y; Jiang J; Wang Z; Wei J; Li X; Wang L; Xia H; Li T; Liu S; Xing B; Yang Z; Lu Q; Jiang R; Xie P; Shou X; Wang X; Jia Y
    Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1183-91. PubMed ID: 24757084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate: an analysis of the ASSOCIATE study.
    Tardif JC; Ponikowski P; Kahan T;
    Int J Cardiol; 2013 Sep; 168(2):789-94. PubMed ID: 23138014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
    Ruzyllo W; Tendera M; Ford I; Fox KM
    Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ivabradine: new drug. Best avoided in stable angina.
    Prescrire Int; 2007 Apr; 16(88):53-6. PubMed ID: 17458043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.
    Tardif JC; Ponikowski P; Kahan T;
    Eur Heart J; 2009 Mar; 30(5):540-8. PubMed ID: 19136486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.
    Tardif JC; Ford I; Tendera M; Bourassa MG; Fox K;
    Eur Heart J; 2005 Dec; 26(23):2529-36. PubMed ID: 16214830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A possibility to interchange heart rate-slowing therapy with ivabradine and atenolol in patients with stable angina pectoris].
    Shavarov AA; Kiiakbaev GK; Kobalava ZhD
    Ter Arkh; 2013; 85(4):77-83. PubMed ID: 23808298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial.
    Borer JS; Fox K; Jaillon P; Lerebours G;
    Circulation; 2003 Feb; 107(6):817-23. PubMed ID: 12591750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: age-related results from the ADDITIONS study.
    Müller-Werdan U; Stöckl G; Ebelt H; Nuding S; Höpfner F; Werdan K;
    Exp Gerontol; 2014 Nov; 59():34-41. PubMed ID: 25193811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of ivabradine in combination with Beta-blocker versus uptitration of Beta-blocker in patients with stable angina.
    Amosova E; Andrejev E; Zaderey I; Rudenko U; Ceconi C; Ferrari R
    Cardiovasc Drugs Ther; 2011 Dec; 25(6):531-7. PubMed ID: 21830063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Anginal and Metabolic Effects of Carvedilol and Atenolol in Patients with Stable Angina Pectoris: A Prospective, Randomized, Parallel, Open-Label Study.
    Oh PC; Kang WC; Moon J; Park YM; Kim S; Kim MG; Lee K; Ahn T; Shin EK
    Am J Cardiovasc Drugs; 2016 Jun; 16(3):221-8. PubMed ID: 27021556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised, double-blind, three-way cross-over study of dilevalol 200 and 400 mg and atenolol 100 mg once-daily in patients with chronic stable angina pectoris.
    Bowles MJ; Smith L; Glover DR
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():85-90. PubMed ID: 2196372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmyocardial infarction remodeling and coronary reserve: effects of ivabradine and beta blockade therapy.
    Christensen LP; Zhang RL; Zheng W; Campanelli JJ; Dedkov EI; Weiss RM; Tomanek RJ
    Am J Physiol Heart Circ Physiol; 2009 Jul; 297(1):H322-30. PubMed ID: 19411283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ivabradine improves all aspects of quality of life assessed with the 36-item short form health survey in subjects with chronic ischemic heart disease compared with beta-blockers.
    Riccioni G; Prencipe G; Benvenuto A; Masciocco L; Ventra S; Rizzo U; Russi C; Speziale G
    Pharmacology; 2013; 91(1-2):35-8. PubMed ID: 23146926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
    Rousseau MF; Pouleur H; Cocco G; Wolff AA
    Am J Cardiol; 2005 Feb; 95(3):311-6. PubMed ID: 15670536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the effects and safety of atenolol and nifedipine in the treatment of angina pectoris].
    Aschermann M; Bultas J; Danzig V; Mayer O; Lorenc Z; Vortel J; Kvasnicka J
    Vnitr Lek; 1993 Apr; 39(4):345-52. PubMed ID: 8351862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of ivabradine, a selective I(f) inhibitor, in patients with chronic stable angina pectoris and diabetes mellitus.
    Borer JS; Tardif JC
    Am J Cardiol; 2010 Jan; 105(1):29-35. PubMed ID: 20102886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Ivabradine in Treating Stable Angina Pectoris.
    Ye L; Ke D; Chen Q; Li G; Deng W; Wu Z
    Medicine (Baltimore); 2016 Apr; 95(14):e3245. PubMed ID: 27057864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of metoprolol OROS with antenolol in the treatment of effort angina pectoris: a randomized double-blind study.
    Floris B; Paoletti G; Pelizza L; Bertulla A; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1991 Apr; 29(4):139-43. PubMed ID: 1906434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of trimetazidine on functional capacity in symptomatic patients with stable exertional angina--the VASCO-angina study.
    Vitale C; Spoletini I; Malorni W; Perrone-Filardi P; Volterrani M; Rosano GM
    Int J Cardiol; 2013 Sep; 168(2):1078-81. PubMed ID: 23200272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.